The role of serotonin in respiratory function and dysfunction

Respiratory Physiology and Neurobiology

Volumn 174, Issue 1-2, 2010, Pages 76-88

  Hilaire, Gérard ^a   Voituron, Nicolas ^a   Menuet, Clément ^a   Ichiyama, Ronaldo M ^b   Subramanian, Hari H ^b   Dutschmann, Mathias ^b  

^a CNRS   (France)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

5 HT; Development; Neurodegeneration; Respiratory disorders; Respiratory rhythm

Indexed keywords

SEROTONIN;

BRAIN STEM; BREATHING DISORDER; DEVELOPMENTAL DISORDER; HUMAN; MEDULLA OBLONGATA; MENTAL DISEASE; NERVE CELL NETWORK; NERVE DEGENERATION; NONHUMAN; PONS; PRADER WILLI SYNDROME; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; RETT SYNDROME; REVIEW; SEROTONINERGIC SYSTEM; SLEEP APNEA SYNDROME; SUDDEN INFANT DEATH SYNDROME;

ANIMALS; BRAIN; DEVELOPMENTAL DISABILITIES; HUMANS; NERVOUS SYSTEM DISEASES; NEURONS; RECEPTORS, SEROTONIN; RESPIRATION; RESPIRATION DISORDERS; SEROTONIN;

EID: 78049404765     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2010.08.017     Document Type: Review

References (204)

1. Abad V.C., Guilleminault C. Pharmacological management of sleep apnoea. Expert Opin. Pharmacother. 2006, 7:11-23.
2. Aghajanian G.K., Sprouse J.S., Sheldon P., Rasmussen K. Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms. Ann. N. Y. Acad. Sci. 1990, 600:93-103.
3. Akefeldt A., Ekman R., Gillberg C., Månsson J.E. Cerebrospinal fluid monoamines in Prader-Willi syndrome. Biol. Psychiatry 1998, 44:1321-1328.
4. Alenina N., Bashammakh S., Bader M. Specification and differentiation of serotonergic neurons. Stem Cell Rev. 2006, 2:5-10.
5. Amiel J., Dubreuil V., Ramanantsoa N., Fortin G., Gallego J., Brunet J.F., Goridis C. PHOX2B in respiratory control: lessons from congenital central hypoventilation syndrome and its mouse models. Respir. Physiol. Neurobiol. 2009, 168:125-132.
6. Andaku D.K., Mercadante M.T., Schwartzman J.S. Buspirone in Rett syndrome respiratory dysfunction. Brain Dev. 2005, 27:437-438.
7. Attems J., Quass M., Jellinger K.A. Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. Acta Neuropathol. 2007, 113:53-62.
8. Audero E., Coppi E., Mlinar B., Rossetti T., Caprioli A., Banchaabouchi M.A., Corradetti R., Gross C. Sporadic autonomic dysregulation and death associated with excessive serotonin autoinhibition. Science 2008, 321(5885):130-1333.
9. Benarroch E.E. New findings on the neuropathology of multiple system atrophy. Auton. Neurosci. 2002, 96:59-62.
10. Benarroch E.E., Schmeichel A.M., Low P.A., Parisi J.E. Involvement of medullary serotonergic groups in multiple system atrophy. Ann. Neurol. 2004, 55:418-422.
11. Benarroch E.E. Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy. Mov. Disord. 2007, 22:155-161.
12. Benarroch E.E., Schmeichel A.M., Sandroni P., Parisi J.E., Low P.A. Rostral raphe involvement in Lewy body dementia and multiple system atrophy. Acta Neuropathol. 2007, 114:213-220.
13. Berkowitz R.G., Sun Q.J., Goodchild A.K., Pilowsky P.M. Serotonin inputs to laryngeal constrictor motoneurons in the rat. Laryngoscope 2005, 115:105-109.
14. Bernard D.G., Li A., Nattie E.E. Evidence for central chemoreception in the midline raphé. J. Appl. Physiol. 1996, 80:108-115.
15. Blessing W.W., Nalivaiko E. Regional blood flow and nociceptive stimuli in rabbits: patterning by medullary raphe, not ventrolateral medulla. J. Physiol. 2000, 524:279-292.
16. Bliwise D.L. Sleep apnea, APOE4 and Alzheimer's disease 20 years and counting?. J. Psychosom. Res. 2002, 53:539-546.
17. Bliwise D.L. Sleep disorders in Alzheimer's disease and other dementias. Clin. Cornerstone 2004, 6(Suppl. 1A):S16-S28.
18. Bou-Flores C., Lajard A.M., Monteau R., De Maeyer E., Seif I., Lanoir J., Hilaire G. Abnormal phrenic motoneuron activity and morphology in neonatal monoamine oxidase A-deficient transgenic mice: possible role of a serotonin excess. J. Neurosci. 2000, 20:4646-4656.
19. Bras H., Gaytán S.P., Portalier P., Zanella S., Pásaro R., Coulon P., Hilaire G. Prenatal activation of 5-HT2A receptor induces expression of 5-HT1B receptor in phrenic motoneurons and alters the organization of their premotor network in newborn mice. Eur. J. Neurosci. 2008, 28(6):1097-1107.
20. Burlhis T.M., Aghajanian G.K. Pacemaker potentials of serotonergic dorsal raphe neurons: contribution of a low-threshold Ca2+ conductance. Synapse 1987, 1:582-588.
21. Burnet H., Bevengut M., Chakri F., Bou-Flores C., Coulon P., Gaytan S., Pasaro R., Hilaire G. Altered respiratory activity and respiratory regulations in adult monoamine oxidase A-deficient mice. J. Neurosci. 2001, 21(14):5212-5221.
22. Burns J.M., Cronk B.B., Anderson H.S., Donnelly J.E., Thomas G.P., Harsha A., Brooks W.M., Swerdlow R.H. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology 2008, 71:210-216.
23. Carley D.W., Olopade C., Ruigt G.S., Radulovacki M. Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep 2007, 30:35-41.
24. Caroff J., Girin E., Alix D., Cann-Moisan C., Sizun J., Barthelemy L. Neurotransmission and sudden infant death. Study of cerebrospinal fluid. C R Acad. Sci. III 1992, 314(10):451-454.
25. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Müller U., Aguet M., Babinet C., Shih J.C., Cases O., Vitalis T., Seif I., De Maeyer E., Sotelo C., Gaspar P. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 1996, 16:297-307.
26. Cazalets J.R., Gardette M., Hilaire G. Locomotor network maturation is transiently delayed in the MAOA-deficient mouse. J. Neurophysiol. 2000, 83:2468-2470.
27. Connely C.A., Elllenberger H.H., Feldman J.L. Are there serotonergic projections from raphe and retrotrapezoid nuclei to the ventral respiratory group in the rat?. Neurosci. Lett. 1989, 105:30-40.
28. Cooke J.R., Liu L., Natarajan L., He F., Marler M., Loredo J.S., Corey-Bloom J., Palmer B.W., Greenfield D., Ancoli-Israel S. The effect of sleep-disordered breathing on stages of sleep in patients with Alzheimer's disease. Behav. Sleep Med. 2006, 4:219-227.
29. Cooke J.R., Ayalon L., Palmer B.W., Loredo J.S., Corey-Bloom J., Natarajan L., Liu L., Ancoli-Israel S. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. J. Clin. Sleep Med. 2009, 5:305-309.
30. Cooke J.R., Ancoli-Israel S., Liu L., Loredo J.S., Natarajan L., Palmer B.S., He F., Corey-Bloom J. Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea. Sleep Med. 2009, 10(10):1101-1106.
31. Cooper J.R., Bloom F.E., Roth R.H. The Biochemical Basis of Neuropharmacology 1991, Ox Uni Press, Oxford.
32. Corcoran A.E., Hodges M.R., Wu Y., Wang W., Wylie C.J., Deneris E.S., Richerson G.B. Medullary serotonin neurons and central CO2 chemoreception. Respir. Physiol. Neurobiol. 2009, 168:49-58.
33. Coryell W., Rickels H. Effects of escitalopram on anxiety and respiratory responses to carbon dioxide inhalation in subjects at high risk for panic disorder: a placebo-controlled, crossover study. J. Clin. Psychopharmacol. 2009, 29:174-178.
34. Dahlström A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 1964, 62(Suppl. 232):1-55.
35. Dempsey J.A., Olsen E.B., Skatrud J.B. Hormones and neurochemicals in the regulation of breathing. The Handbook of Physiology - The Respiratory System II 1987, APS, Washington DC, pp. 181-221, Chapter 7. A.P. Fishman, N.S. Cherniak, J.G. Widdicombe, S.R. Geiger (Eds.).
36. Di Pasquale E., Morin D., Monteau R., Hilaire G. Serotonergic modulation of the respiratory rhythm generator at birth: an in vitro study in the rat. Neurosci. Lett. 1992, 143:91-95.
37. Di Pasquale E., Lindsay A., Feldman J.L., Monteau R., Hilaire G. Serotonergic inhibition of phrenic motoneuron activity: an in vitro study in neonatal rat. Neurosci. Lett. 1997, 230:29-32.
38. Dias M.B., Nucci T.B., Margatho L.O., Antunes-Rodrigues J., Gargaglioni L.H., Branco L.G. Raphe magnus nucleus is involved in ventilatory but not hypothermic response to CO2. J. Appl. Physiol. 2007, 103(5):1780-1788.
39. Ding Y.Q., Marklund U., Yuan W., Yin J., Wegman L., Ericson J., Deneris E., Johnson R.L., Chen Z.F. Lmx1b is essential for the development of serotonergic neurons. Nat. Neurosci. 2003, 6(9):933-938.
40. Douglan W.W., Toh C.C. The respiratory stimulamnt action of 5-Hydroxytryptamine (serotonin) in the dog. J. Physiol. 1953, 120:311-318.
41. Duncan J.R., Paterson D.S., Hoffman J.M., Mokler D.J., Borenstein N.S., Belliveau R.A., Krous H.F., Haas E.A., Stanley C., Nattie E.E., Trachtenberg F.L., Kinney H.C. Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA 2010, 303:430-437.
42. Dutschmann M., Mörschel M., Kron M., Herbert H. Development of adaptive behaviour of the respiratory network: implications for the pontine Kolliker-Fuse nucleus. Respir. Physiol. Neurobiol. 2004, 143:155-165.
43. Dutschmann M., Waki H., Manzke T., Simms A.E., Pickering A.E., Richter D.W., Paton J.F. The potency of different serotonergic agonists in counteracting opioid evoked cardiorespiratory disturbances. Philos. Trans. R Soc. Lond. B Biol. Sci. 2009, 364:2611-2623.
44. Dutschmann M., Menuet C., Stettner G.M., Gestreau C., Borghgraef P., Devijver H., Gielis L., Hilaire G., Van Leuven F. Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei. J. Neurosci. 2010, 30:1810-1821.
45. El-Khatib M.F., Kiwan R.A., Jamaleddine G.W. Buspirone treatment for apneustic breathing in brain stem infarct. Respir. Care 2003, 48:956-958.
46. Erickson J.T., Shafer G., Rossetti M.D., Wilson C.G., Deneris E.S. Arrest of 5HT neuron differentiation delays respiratory maturation and impairs neonatal homeostatic responses to environmental challenges. Respir. Physiol. Neurobiol. 2007, 159:85-101.
47. Erspamer V., Vialli M. Ricerche sul secreto delle cellule enterocromaffini. Boll. d Soc. Med-chir Pavia. 1937, 51:357-363.
48. Falck B. Observations on the possibilities of the cellular localization of monoamines by a fluorescence method. Acta Physiol. Scand. 1962, 56(Suppl. 197):1-25.
49. Falck B., Hillarp N.A., Thieme G., Torp A. Fluorescence of catechol amines and related compounds condensed with formaldehyde. J. Histochem. Cytochem. 1962, 10:348-354.
50. Fallert M., Böhmer G., Dinse H.R., Sommer T.J., Bittner A. Microelectrophoretic application of putative neurotransmitters onto various types of bulbar respiratory neurons. Arch. Ital. Biol. 1979, 117:1-12.
51. Feldman J.L., Mitchell G.S., Nattie E.E. Breathing: rhythmicity, plasticity, chemosensitivity. Annu. Rev. Neurosci. 2003, 26:239-266.
52. Festen D.A., de Weerd A.W., van den Bossche R.A., Joosten K., Hoeve H., Hokken-Koelega A.C. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. J. Clin. Endocrinol. Metab. 2006, 91(12):4911-4915.
53. Fortin G., Thoby-Brisson M. Embryonic emergence of the respiratory rhythm generator. Respir. Physiol. Neurobiol. 2009, 168:86-91.
54. Gaddum J.H., Picarelli Z.P. Two kinds of tryptamine receptors. Br. J. Pharmacol. 1957, 12:323-328.
55. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4(12):1002-1012.
56. Gaspar P. Genetic models to understand how 5-HT acts during development. J. Soc. Biol. 2004, 198:18-21.
57. Gestreau C., Dutschmann M., Obled S., Bianchi A.L. Activation of XII motoneurons and premotor neurons during various oropharyngeal behaviors. Respir. Physiol. Neurobiol. 2005, 147:159-176.
58. Ginzel K.H., Kottegoda S.R. The action of 5-hydroxytryptamine and tryptamine on aortic and carotid sinus receptors in the cat. J. Physiol. 1954, 123:277-288.
59. Goldstone A.P. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol. Metab. 2004, 15:12-20.
60. Gorman J.M., Fyer M.R., Goetz R., Askanazi J., Liebowitz M.R., Fyer A.J., Kinney J., Klein D.F. Ventilatory physiology of patients with panic disorder. Arch. Gen. Psychiatry 1988, 45:31-39.
61. Grinberg L.T., Rüb U., Ferretti R.E., Nitrini R., Farfel J.M., Polichiso L., Gierga K., Jacob-Filho W., Heinsen H. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?. Neuropathol. Appl. Neurobiol. 2009, 35:406-416. Brazilian Brain Bank Study Group.
62. Guenther U., Manzke T., Wrigge H., Dutschmann M., Zinserling J., Putensen C., Hoeft A. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo. Anesth. Analg. 2009, 108:1169-1176.
63. Guo X., Waern M., Sjögren K., Lissner L., Bengtsson C., Björkelund C., Ostling S., Gustafson D., Skoog I. Midlife respiratory function and incidence of Alzheimer's disease: a 29-year longitudinal study in women. Neurobiol. Aging 2007, 28:343-350.
64. Guyenet P.G., Bayliss D.A., Stornetta R.L., Fortuna M.G., Abbott S.B., DePuy S.D. Retrotrapezoid nucleus, respiratory chemosensitivity and breathing automaticity. Respir. Physiol. Neurobiol. 2009, 168:59-68.
65. Hedner T., Lundborg P., Engel J. Effect of hypoxia on monoamine synthesis in brains of developing rats. III. Various O2 levels. Biol. Neonate 1978, 34:55-60.
66. Hendricks T., Francis N., Fyodorov D., Deneris E.S. The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J. Neurosci. 1999, 19(23):10348-10356.
67. Hendricks T.J., Fyodorov D.V., Wegman L.J., Lelutiu N.B., Pehek E.A., Yamamoto B., Silver J., Weeber E.J., Sweatt J.D., Deneris E.S. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 2003, 37:233-247.
68. Hendricksen M., Thomas A.J., Ferrier I.N., Ince P., O'Brien J.T. Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression. Am. J. Psychiatry 2004, 161(6):1096-1102.
69. Hermann D.M., Luppi P.H., Peyron C., Hinckel P., Jouvet M. Forebrain projections of the rostral nucleus raphe magnus shown by iontophoretic application of choleratoxin b in rats. Neurosci. Lett. 1996, 216:151-154.
70. Hermann D.M., Luppi P.H., Peyron C., Hinckel P., Jouvet M. Afferent projections to the rat nuclei raphe magnus, raphe pallidus and reticularis gigantocellularis pars alpha demonstrated by iontophoretic application of choleratoxin (subunit b). J. Chem. Neuroanat. 1997, 13:1-21.
71. Hilaire G., Morin D., Lajard A.M., Monteau R. Changes in serotonin metabolism may elicit obstructive apnoea in the newborn rat. J. Physiol. 1993, 466:367-381.
72. Hilaire G. Endogenous noradrenaline affects the maturation and function of the respiratory network: possible implication for SIDS. Auton. Neurosci. 2006, 126-127:320-331.
73. Hillert D. On processing lexical meanings in aphasia and Alzheimer's disease: some (re)considerations. Brain Lang. 1999, 69:95-118.
74. Hodges M.R., Richerson G.B. Interaction between defects in ventilatory and thermoregulatory control in mice lacking 5-HT neurons. Respir. Physiol. Neurobiol. 2008, 164:350-357.
75. Hodges M.R., Tattersall G.J., Harris M.B., McEvoy S.D., Richerson D.N., Deneris E.S., Johnson R.L., Chen Z.F., Richerson G.B. Defects in breathing and thermoregulation in mice with near-complete absence of central serotonin neurons. J. Neurosci. 2008, 28(10):2495-2505.
76. Hodges M.R., Richerson G.B. The role of medullary 5-HT (5-HT) neurons in respiratory control: contributions to eupneic ventilation, CO2 chemoreception, and thermoregulation. J. Appl. Physiol. 2010, 108(5):1425-1432.
77. Holtman J.R., Dick T.E., Berjer A.J. Involvement of serotonin in the excitation of phrenic motoneurons evoked by stimulation of raphe obscurus. J. Neurosci. 1986, 6:1185-1193.
78. Holtman J.R., Dick T.E., Berjer A.J. Serotonin mediated excitation of recurrent laryngeal and phrenic motoneurons evoked by stimulation of raphe obscurus. Brain Res. 1987, 417:12-20.
79. Holtman J.R. Immunohistochemical localization of serotonin and substance P containing fibers around respiratory muscle motoneurons in the nucleus ambiguss of the cat. Neuroscience 1988, 26:169-178.
80. Hornung J.P. The human raphe nuclei and the serotonergic system. J. Chem. Neuroanat. 2003, 26:331-343.
81. Hoyer D., Clarke D.E., Fozard J.R., Harting P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII International union of pharmacology classification of receptors for 5-hydroxytryptamine. Pharmacol. Rev. 1994, 46:157-203.
82. Hunt P.N., McCabe A.K., Bosma M.M. Midline serotonergic neurones contribute to widespread synchronized activity in embryonic mouse hindbrain. J. Physiol. 2005, 566:807-819.
83. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 1992, 72:165-229.
84. Kalia M. Dysphagia and aspiration pneumonia in patients with Alzheimer's disease. Metabolism 2003, 52(Suppl. 2):36-38.
85. Kanamaru M., Homma I. Dorsomedial medullary 5-HT2 receptors mediate immediate onset of initial hyperventilation, airway dilation, and ventilatory decline during hypoxia in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R34-R41.
86. Katz D.M., Dutschmann M., Ramirez J.M., Hilaire G. Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir. Physiol. Neurobiol. 2009, 168:101-108.
87. Khater-Boidin J., Rose D., Duron B. Central effects of 5-HT on activity of respiratory and hypoglossally innervated muscles in newborn kittens. J. Physiol. 1996, 495:255-265.
88. Kinney H.C., Belliveau R.A., Trachtenberg F.L., Rava L.A., Paterson D.S. The development of the medullary serotonergic system in early human life. Auton. Neurosci. 2007, 132:81-102.
89. Klein D.F. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch. Gen. Psychiatry 1993, 50:306-317.
90. Kuhn D.M., Arthur R.E. Inactivation of brain tryptophan hydroxylase by nitric oxide. J. Neurochem. 1996, 67(3):1072-1077.
91. Kuhn D.M., Arthur R.E. Inactivation of tryptophan hydroxylase by nitric oxide: enhancement by tetrahydrobiopterin. J. Neurochem. 1997, 68(4):1495-1502.
92. Lai M.K., Tsang S.W., Francis P.T., Esiri M.M., Keene J., Hope T., Chen C.P. Reduced 5-HT 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res. 2003, 974:82-87.
93. Lajard A.M., Bou C., Monteau R., Hilaire G. Serotonin levels are abnormally elevated in the fetus of the monoamine oxidase-A-deficient transgenic mouse. Neurosci. Lett. 1999, 261:41-44.
94. Lalley P.M., Bischoff A.M., Richter D.W. 5-HT-1A receptor-mediated modulation of medullary expiratory neurones in the cat. J. Physiol. 1994, 476:117-130.
95. Lalley P.M., Bischoff A.M., Richter D.W. Serotonin 1A-receptor activation suppresses respiratory apneusis in the cat. Neurosci. Lett. 1994, 172:59-62.
96. Lalley P.M., Bischoff A.M., Schwarzacher S.W., Richter D.W. 5-HT2 receptor-controlled modulation of medullary respiratory neurones in the cat. J. Physiol. 1995, 487:653-661.
97. Lalley P.M., Benacka R., Bischoff A.M., Richter D.W. Nucleus raphe obscurus evokes 5-HT-1A receptor-mediated modulation of respiratory neurons. Brain Res. 1997, 747:156-159.
98. Lanoir J., Hilaire G., Seif I. Reduced density of functional 5-HT1A receptors in the brain, medulla and spinal cord of monoamine oxidase-A knockout mouse neonates. J. Comp. Neurol. 2006, 495(5):607-623.
99. Lauterbach E.C., Victoroff J., Coburn K.L., Shillcutt S.D., Doonan S.M., Mendez M.F. Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data. J. Neuropsychiatry Clin. Neurosci. 2010, 22:8-18.
100. Lavie P., Lavie L. Cardiovascular morbidity and mortality in obstructive sleep apnea. Curr. Pharm. Des. 2008, 14(32):3466-3473.
101. Lebrand C., Cases O., Adelbrecht C., Doye A., Alvarez C., El Mestikawy S., Seif I., Gaspar P. Transient uptake and storage of 5-HT in developing thalamic neurons. Neuron 1996, 17:823-835.
102. Lebrand C., Cases O., Wehrleó R., Blakely R.D., Edwards R.H., Gaspar P. Transient developmental expression of monoamine transporters in the rodent forebrain. J. Comp. Neurol. 1998, 401:506-524.
103. Lee S., Walker C.L., Wevrick R. Prader-Willi syndrome transcripts are expressed in phenotypically significant regions of the developing mouse brain. Gene Expr. Patterns 2003, 3(5):599-609.
104. Léger L., Wiklund L., Descarries L., Persson M. Description of an indolaminergic cell component in the cat locus coeruleus: a fluorescence histochemical and radioautographic study. Brain Res. 1979, 168:43-56.
105. Leger L., Charnay Y., Hof P.R., Bouras C., Cespuglio R. Anatomical distribution of serotonin-containing neurons and axons in the central nervous system of the cat. J. Comp. Neurol. 2001, 433:157-182.
106. Li A., Nattie E.E. Serotonin transporter knockout mice have a reduced ventilatory response to hypercapnia (predominantly in males) but not to hypoxia. J. Physiol. 2008, 586:2321-2329.
107. Lindsay A.D., Feldman J.L. Modulation of respiratory activity of neonatal rat phrenic motoneurones by serotonin. J. Physiol. 1993, 461:213-233.
108. Liu Q., Wong-Riley M.T. Postnatal changes in tryptophan hydroxylase and serotonin transporter immunoreactivity in multiple brainstem nuclei of the rat: implications for a sensitive period. J. Comp. Neurol. 2010, 518:1082-1097.
109. Lötsch J., Skarke C., Schneider A., Hummel T., Geisslinger G. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression. Clin. Pharmacol. Ther. 2005, 78:278-287.
110. Manaker S., Tischler L.J. Origin of serotonergic afferents to the hypoglossal nucleus in the rat. J. Comp. Neurol. 1993, 334:466-476.
111. Manzke T., Guenther U., Ponimaskin E.G., Haller M., Dutschmann M., Schwarzacher S., Richter D.W. 5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia. Science 2003, 301:226-229.
112. Manzke T., Bidon O., Dutschmann M., Richter D.W. Mecp2-deficiency causes developmental changes in the serotonergic system. Acta Physiol. 2008, 192:PT03-PT05.
113. Manzke T., Dutschmann M., Schlaf G., Morschel M., Koch U.R., Ponimaskin E., Bidon O., Lalley P.M., Richter D.W. Serotonin targets inhibitory synapses to induce modulation of network functions. Philos. Trans. R Soc. Lond. B Biol. Sci. 2009, 364:2589-2602.
114. Martinez J.M., Kent J.M., Coplan J.D., Browne S.T., Papp L.A., Sullivan G.M., Kleber M., Perepletchikova F., Fyer A.J., Klein D.F., Gorman J.M. Respiratory variability in panic disorder. Depress. Anxiety 2001, 14:232-237.
115. McAllen R.M., Tanaka M., Ootsuka Y., McKinley M.J. Multiple thermoregulatory effectors with independent central controls. Eur. J. Appl. Physiol. 2010, 109:27-33.
116. McCann U.D., Sgambati F.P., Schwartz A.R., Ricaurte G.A. Sleep apnea in young abstinent recreational MDMA (" ecstasy") consumers. Neurology 2009, 73(23):2011-2017.
117. McCrimmon D.R., Lalley P.M. Inhibition of respiratory neural discharges by clonidine and 5-hydroxytryptamine. J. Pharmacol. Exp. Ther. 1982, 2222:771-777.
118. Michelson A.L., Hollander W., Lowell F.C. The effect of 5-Hydroxytryptamine on the respiration of non-asthmatic and asthmatic subjects. J. Lab. Clin. Med. 1958, 51:57-62.
119. Minson J., Chalmers J., Drolet G., Kapoor V., Llewellyn-Smith I., Mills E., Morris M., Pilowsky P. Central serotonergic mechanisms in cardiovascular regulation. Cardiovasc. Drugs Ther. 1990, 4(Suppl. 1):27-32.
120. Monteau R., Hillaire G. Spinal respiratory motoneurons. Prog. Neurobiol. 1991, 37:83-144.
121. Morin D., Hennequin S., Monteau R., Hilaire G. Serotonergic influences on central respiratory activity: an in vitro study in the newborn rat. Brain Res. 1990, 535:281-287.
122. Morin D., Monteau R., Hilaire G. Compared effects of serotonin on cervical and hypoglossal inspiratory activities: an in vitro study in the newborn rat. J. Physiol. 1992, 451:605-629.
123. Morley M.E., Rand C.M., Berry-Kravis E.M., Zhou L., Fan W., Weese-Mayer D.E. Genetic variation in the HTR1A gene and sudden infant death syndrome. Am. J. Med. Genet. A 2008, 146(7):930-933.
124. Morrison S.F., Nakamura K., Madden C.J. Central control of thermogenesis in mammals. Exp. Physiol. 2008, 93(7):773-797.
125. Mulkey D.K., Rosin D.L., West G., Takakura A.C., Moreira T.S., Bayliss D.A., Guyenet P.G. Serotonergic neurons activate chemosensitive retrotrapezoid nucleus neurons by a pH-independent mechanism. J. Neurosci. 2007, 27:14128-14138.
126. Nakamura K., Hasegawa H. Developmental role of tryptophan hydroxylase in the nervous system. Mol. Neurobiol. 2007, 35:45-54.
127. Nalivaiko E., Sgoifo A. Central 5-HT receptors in cardiovascular control during stress. Neurosci. Biobehav. Rev. 2009, 33:95-106.
128. Nardi A.E., Freire R.C., Zin W.A. Panic disorder and control of breathing. Respir. Physiol. Neurobiol. 2009, 167:133-143.
129. Narita N., Narita M., Takashima S., Nakayama M., Nagai T., Okado N. Serotonin transporter gene variation is a risk factor for sudden infant death syndrome in the Japanese population. Pediatrics 2001, 107(4):690-692.
130. Nattie E.E., Li A. CO2 dialysis in the medullary raphe of the rat increases ventilation in sleep. J. Appl. Physiol. 2001, 90(4):1247-1257.
131. Nattie E.E., Li A., Richerson G.B., Lappi D.A. Medullary serotonergic neurones and adjacent neurones that express neurokinin-1 receptors are both involved in chemoreception in vivo. J. Physiol. 2004, 556:235-253.
132. Neugroschl J., Sano M. Current treatment and recent clinical research in Alzheimer's disease. Mt. Sinai J. Med. 2010, 77:3-16.
133. Nixon G.M., Brouillette R.T. Sleep and breathing in Prader-Willi syndrome. Pediatr. Pulmonol. 2002, 34:209-217.
134. Oertel B.G., Schneider A., Rohrbacher M., Schmidt H., Tegeder I., Geisslinger G., Lötsch J. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans. Clin. Pharmacol. Ther. 2007, 81:59-68.
135. Olsen E.B., Dempsey J.A., McCrimmon D.R. Serotonin and the control of ventilation in awake rats. J. Clin. Invest. 1979, 64:689-693.
136. Onimaru H., Ikeda K., Kawakami K. Phox2b, RTN/pFRG neurons and respiratory rhythmogenesis. Respir. Physiol. Neurobiol. 2009, 168:13-18.
137. Ouchi Y., Yoshikawa E., Futatsubashi M., Yagi S., Ueki T., Nakamura K. Altered brain 5-HT transporter and associated glucose metabolism in Alzheimer disease. J. Nucl. Med. 2009, 50(8):1260-1266.
138. Page I.H. The vascular action of natural serotonin 5 and 7-hydroxytryptamine and tryptamine. J. Pharmacol. 1952, 105:58-73.
139. Page I.H., McCubbin J.W. The variable arterial pressure responses to serotonin and laboratory animals and man. Circ. Res. 1953, 1:354-362.
140. Palacios J.M., Waeber C., Hoyer D., Mengod D. Distribution of serotonin receptors. Ann. N. Y. Acad. Sci. 1990, 600:36-52.
141. Papp L.A., Klein D.F., Gorman J.M. Carbon dioxide hypersensitivity, hyperventilation, and panic disorder. Am. J. Psychiatry 1993, 150:1149-1157.
142. Parks V.J., Sandison A.G., Skinner S.L., Whelan R.F. The stimulation of respiration by 5-hydroxytryptamine in man. J. Physiol. 1960, 151:342-351.
143. Parvizi J., Van Hoesen G.W., Damasio A. The selective vulnerability of brainstem nuclei to Alzheimer's disease. Ann. Neurol. 2001, 49:53-66.
144. Paterson D.S., Trachtenberg F.L., Thompson E.G., Belliveau R.A., Beggs A.H., Darnall R., Chadwick A.E., Krous H.F., Kinney H.C. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA 2006, 296(17):2124-2132.
145. Paterson D.S., Hilaire G., Weese-Mayer D.E. Medullary serotonin defects and respiratory dysfunction in sudden infant death syndrome. Respir. Physiol. Neurobiol. 2009, 168:133-143.
146. Pattyn A., Vallstedt A., Dias J.M., Samad O.A., Krumlauf R., Rijli F.M., Brunet J.F., Ericson J. Coordinated temporal and spatial control of motor neuron and serotonergic neuron generation from a common pool of CNS progenitors. Genes Dev. 2003, 17(6):729-737.
147. Pilowsky P.M., de Castro D., Llewellyn-Smith I., Lipski J., Voss M.D. Serotonin immunoreacive boutons make synapses with feline phrenic motoneurons. J. Neurosci. 1990, 10:1091-1098.
148. Poncet L., Denoroy L., Dalmaz Y., Pequignot J.M. Activity of tryptophan hydroxylase and content of indolamines in discrete brain regions after a long-term hypoxic exposure in the rat. Brain Res. 1997, 765:122-128.
149. Poon C.S. Optimal interaction of respiratory and thermal regulation at rest and during exercise: role of a 5-HT-gated spinoparabrachial thermoafferent pathway. Respir. Physiol. Neurobiol. 2009, 169:234-242.
150. Popa D., Léna C., Fabre V., Prenat C., Gingrich J., Escourrou P., Hamon M., Adrien J. Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. J. Neurosci. 2005, 25(49):11231-11238.
151. Prabhakar N.R., Peng Y.J., Yuan G., Kumar G.K. Reactive oxygen species facilitate oxygen sensing. Novartis Found. Symp. 2006, 272:95-99.
152. Rahman M.S., Thomas P. Molecular cloning, characterization and expression of two tryptophan hydroxylase (TPH-1 and TPH-2) genes in the hypothalamus of Atlantic croaker: down-regulation after chronic exposure to hypoxia. Neuroscience 2009, 158:751-765.
153. Ramage A.G., Villalón C.M. 5-hydroxytryptamine and cardiovascular regulation. Trends Pharmacol. Sci. 2008, 29(9):472-481.
154. Rand C.M., Weese-Mayer D.E., Zhou L., Maher B.S., Cooper M.E., Marazita M.L., Berry-Kravis E.M. Sudden infant death syndrome: case-control frequency differences in paired like homeobox Phox2B gene. Am. J. Med. Genet. A 2006, 140(15):1687-1691.
155. Rand C.M., Berry-Kravis E.M., Fan W., Weese-Mayer D.E. HTR2A variation and sudden infant death syndrome: a case-control analysis. Acta Paediatr. 2009, 98:58-61.
156. Rapport M.M., Green A.A., Page I.H. Crystalline serotonin. Science 1948, 108:329-330.
157. Real C., Popa D., Seif I., Callebert J., Launay J.M., Adrien J., Escourrou P. Sleep apneas are increased in mice lacking monoamine oxidase A. Sleep 2007, 30(10):1295-1302.
158. Real C., Seif I., Adrien J., Escourrou P. Ondansetron and fluoxetine reduce sleep apnea in mice lacking monoamine oxidase. Respir. Physiol. Neurobiol. 2009, 168:230-238.
159. Reid G., Rand M. Physiological actions of the partially purified neurons serum vasoconstrictor (serotonin). Aust. J. Exp. Biol. Med. Sci. 1951, 29:401-415.
160. Ren J., Lee S., Pagliardini S., Gérard M., Stewart C.L., Greer J.J., Wevrick R. Absence of Ndn, encoding the Prader-Willi syndrome-deleted gene necdin, results in congenital deficiency of central respiratory drive in neonatal mice. J. Neurosci. 2003, 23(5):1569-1573.
161. Richerson G.B. Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis. Nat. Rev. Neurosci. 2004, 5(6):449-461.
162. Richter D.W., Schmidt-Garcon P., Pierrefiche O., Bischoff A.M., Lalley P.M. Neurotransmitters and neuromodulators controlling the hypoxic respiratory response in anaesthetized cats. J. Physiol. 1999, 514:567-578.
163. Rockhill W., Kirkman J.L., Bosma M.M. Spontaneous activity in the developing mouse midbrain driven by an external pacemaker. Dev. Neurobiol. 2009, 69:689-704.
164. Rosin D.L., Chang D.A., Guyenet P.G. Afferent and efferent connections of the rat retrotrapezoid nucleus. J. Comp. Neurol. 2006, 499:64-89.
165. Rüb U., Del Tredici K., Schultz C., Thal D.R., Braak E., Braak H. The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei. Neuropathol. Appl. Neurobiol. 2000, 26(6):553-567.
166. Rüb U., Del Tredici K., Schultz C., Thal D.R., Braak E., Braak H. The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology. Acta Neuropathol. 2001, 101(6):555-564.
167. Sahibzada N., Ferreira M., Wasserman A.M., Taveira-DaSilva A.M., Gillis R.A. Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors. J. Pharmacol. Exp. Ther. 2000, 292:704-713.
168. Santhosh L., Estok K.M., Vogel R.S., Tamagnan G.D., Baldwin R.M., Mitsis E.M., Macavoy M.G., Staley J.K., van Dyck C.H. Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET. Psychiatry Res. 2009, 173(3):212-217.
169. Schneider J.A., Yonkman F.F. Species differences in the respiratory cardiovascular response to serotonin (5-hydroxytryptamine). J. Pharmacol. 1954, 111:84-98.
170. Smith J.C., Morrison D.E., Ellengerger H.H., Otto M.R., Feldman J.L. Brainstem projections to the major respiratory neuron populations in the medulla of the cat. J. Comp. Neurol. 1989, 281:69-96.
171. Stein M.B., Millar T.W., Larsen D.K., Kryger H. Irregular breathing during sleep in patients with panic disorder. Am. J. Psychiatry 1995, 152:1168-1173.
172. Steinbusch H.W. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 1981, 6:557-618.
173. Steinbusch H.W., Mulder A.H. Serotonin immunoreactive neurons and their projections in the CNS. Handbook of Chemical Neuroanatomy. Classical Transmitters and Transmitter Receptors in the CNS 1984, Vol. 3, Part II. Elsevier Science, New York.
174. Steinbusch H.W., Verhofstad A.A., Penke B., Varga J., Joosten H.W. Immunohistochemical characterization of monoamine-containing neurons in the central nervous system by antibodies to serotonin and noradrenalin. A study in the rat and the lamprey (lampetra fluviatilis). Acta Histochem. Suppl. 1981, 24:107-122.
175. Stettner G.M., Huppke P., Brendel C., Richter D.W., Gärtner J., Dutschmann M. Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-/y knockout mice. J. Physiol. 2007, 579:863-876.
176. Stettner G.M., Zanella S., Huppke P., Gärtner J., Hilaire G., Dutschmann M. Spontaneous central apneas occur in the C57BL/6J mouse strain. Respir. Physiol. Neurobiol. 2008, 160:21-27.
177. Stettner G.M., Zanella S., Hilaire G., Dutschmann M. 8-OH-DPAT suppresses spontaneous central apneas in the C57BL/6J mouse strain. Respir. Physiol. Neurobiol. 2008, 161:10-15.
178. Subramanian H.H., Balnave R.J., Holstege G. The midbrain periaqueductal gray control of respiration. J. Neurosci. 2008, 28(47):12274-12283.
179. Sun Q.J., Berkowitz R.G., Goodchild A.K., Pilowsky P.M. Serotonin inputs to inspiratory laryngeal motoneurons in the rat. J. Comp. Neurol. 2002, 451:91-98.
180. Taylor N.C., Li A., Nattie E.E. Medullary serotonergic neurones modulate the ventilatory response to hypercapnia, but not hypoxia in conscious rats. J. Physiol. 2005, 566:543-557.
181. Thoby-Brisson M., Karlén M., Wu N., Charnay P., Champagnat J., Fortin G. Genetic identification of an embryonic parafacial oscillator coupling to the preBötzinger complex. Nat. Neurosci. 2009, 12(8):1028-1035.
182. Tork I., Hornung J.P. Raphe nuclei and the serotonergic system. The Human Nervous System 1990, 1001-1022. Academic Press, San Diego, CA. Paxinos (Ed.).
183. Tsang S.W., Keene J., Hope T., Spence I., Francis P.T., Wong P.T., Chen C.P., Lai M.K. A 5-HTergic basis for hyperphagic eating changes in Alzheimer's disease. J. Neurol. Sci. 2010, 288:151-155.
184. Twarog B.M., Page I.H. Serotonin content of some mammalian tissues and urine and a method for its determination. Am. J. Physiol. 1953, 175:157-161.
185. Twarog B.M. Responses of a molluscan smooth muscle to acetylcholine and 5-hydroxytryptamine. J. Cell. Comp. Physiol. 1954, 44:141-163.
186. Upton A.L., Salichon N., Lebrand C., Ravary A., Blakely R., Seif I., Gaspar P. Excess of serotonin (5-HT) alters the segregation of ispilateral and contralateral retinal projections in monoamine oxidase A knock-out mice: possible role of 5-HT uptake in retinal ganglion cells during development. J. Neurosci. 1999, 19(16):7007-7024.
187. Viemari J.C., Roux J.C., Tryba A.K., Saywell V., Burnet H., Peña F., Zanella S., Bévengut M., Barthelemy-Requin M., Herzing L.B., Moncla A., Mancini J., Ramirez J.M., Villard L., Hilaire G. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J. Neurosci. 2005, 25(50):11521-11530.
188. Voituron N., Zanella S., Menuet C., Dutschmann M., Hilaire G. Early breathing defects after moderate hypoxia or hypercapnia in a mouse model of Rett syndrome. Respir. Physiol. Neurobiol. 2009, 168:109-118.
189. Voituron N., Zanella S., Menuet C., Lajard A.M., Dutschmann M., Hilaire G. Early abnormalities of post-sigh breathing in a mouse model of Rett syndrome. Respir. Physiol. Neurobiol. 2010, 170:173-182.
190. Voituron N., Zanella S., Menuet C., Dutschmann M., Hilaire G. Physiological definition of upper airway obstructions in mouse model for Rett Syndrome. Respir. Physiol. Neurobiol. 2010, 10.1016/j.resp.2010.07.006.
191. Voss M.D., de Castro D., Lipski J., Pilowsky P.M., Jiang C. Serotonin immunoreactive boutons form close appositions with respiratory neurons of the dorsal respiratory group in the cat. J. Comp. Neurol. 1990, 295:208-218.
192. Weese-Mayer D.E., Berry-Kravis E.M., Maher B.S., Silvestri J.M., Curran M.E., Marazita M.L. Sudden infant death syndrome: association with a promoter polymorphism of the serotonin transporter gene. Am. J. Med. Genet. 2003, 117A:268-274.
193. Weese-Mayer D.E., Zhou L., Berry-Kravis E.M., Maher B.S., Silvestri J.M., Marazita M.L. Association of the serotonin transporter gene with sudden infant death syndrome: a haplotype analysis. Am. J. Med. Genet. 2003, 122A:238-245.
194. Weese-Mayer D.E., Lieske S.P., Boothby C.M., Kenny A.S., Bennett H.L., Silvestri J.M., Ramirez J.M. Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr. Res. 2006, 60(4):443-449.
195. Weese-Mayer D.E., Lieske S.P., Boothby C.M., Kenny A.S., Bennett H.L., Ramirez J.M. Autonomic dysregulation in young girls with Rett Syndrome during nighttime in-home recordings. Pediatr. Pulmonol. 2008, 43(11):1045-1060.
196. Wilken B., Lalley P.M., Bischoff A.M., Christen H.J., Behnke J., Hanefeld F., Richter D.W. Treatment of apneustic respiratory disturbance with a serotonin-receptor agonist. J. Pediatr. 1997, 130:89-94.
197. Woolley D.W. The Biochemical Bases of Psychoses or the Serotonin Hypothesis about Mental Illness 1963, John Wiley and Sons, Inc., New York, NY.
198. Yamauchi M., Ocak H., Dostal J., Jacono F.J., Loparo K.A., Strohl K.P. Post-sigh breathing behavior and spontaneous pauses in the C57BL/6J (B6) mouse. Respir. Physiol. Neurobiol. 2008, 162:117-125.
199. Yeung, L.Y., Kung, H.F., Yew, D.T., 2010. Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals. Age (Dordr), in press.
200. Yue W., Liu H., Zhang J., Zhang X., Wang X., Liu T., Liu P., Hao W. Association study of 5-HT transporter gene polymorphisms with obstructive sleep apnea syndrome in Chinese Han population. Sleep 2008, 31(11):1535-1541.
201. Zanella S., Watrin F., Mebarek S., Marly F., Roussel M., Gire C., Diene G., Tauber M., Muscatelli F., Hilaire G. Necdin plays a role in the serotonergic modulation of the mouse respiratory network: implication for Prader-Willi syndrome. J. Neurosci. 2008, 28(7):1745-1755.
202. Zanella S., Tauber M., Muscatelli F. Breathing deficits of the Prader-Willi syndrome. Respir. Physiol. Neurobiol. 2009, 168:119-124.
203. Zhan W.Z., Ellenberger H.H., Feldman J.L. Monoaminergic and GABAergic terminations in the phrenic nucleus of rat identified by immunohistochemical labelling. Neuroscience 1989, 31:105-113.
204. Zhao Z.Q., Scott M., Chiechio S., Wang J.S., Renner K.J., Gereau R.W., Johnson R.L., Deneris E.S., Chen Z.F. Lmx1b is required for maintenance of central serotonergic neurons and mice lacking central serotonergic system exhibit normal locomotor activity. J. Neurosci. 2006, 26(49):12781-12788.